Ernexa Therapeutics Announces Participation in the D. Boral Capital Inaugural Global Conference
Ernexa Therapeutics (NASDAQ: ERNA) has announced its participation in the upcoming D. Boral Capital Inaugural Global Conference, scheduled for May 14, 2025, at The Plaza Hotel in New York City. The company's President & CEO, Sanjeev Luther, will be available for one-on-one meetings with interested parties from 9:00 A.M. to 3:00 P.M. (ET). Attendees wishing to schedule meetings can contact John Perez at jperez@dboralcapital.com.
Ernexa Therapeutics (NASDAQ: ERNA) ha annunciato la sua partecipazione al prossimo D. Boral Capital Inaugural Global Conference, previsto per il 14 maggio 2025 presso il The Plaza Hotel di New York City. Il Presidente e CEO della società, Sanjeev Luther, sarà disponibile per incontri individuali con le parti interessate dalle 9:00 alle 15:00 (ET). I partecipanti che desiderano fissare un appuntamento possono contattare John Perez all'indirizzo jperez@dboralcapital.com.
Ernexa Therapeutics (NASDAQ: ERNA) ha anunciado su participación en la próxima D. Boral Capital Inaugural Global Conference, programada para el 14 de mayo de 2025 en The Plaza Hotel en la ciudad de Nueva York. El Presidente y CEO de la compañía, Sanjeev Luther, estará disponible para reuniones individuales con interesados desde las 9:00 a.m. hasta las 3:00 p.m. (ET). Los asistentes que deseen agendar reuniones pueden contactar a John Perez en jperez@dboralcapital.com.
Ernexa Therapeutics (NASDAQ: ERNA)는 2025년 5월 14일 뉴욕 시 플라자 호텔에서 열리는 D. Boral Capital Inaugural Global Conference에 참가한다고 발표했습니다. 회사의 사장 겸 CEO인 Sanjeev Luther는 오전 9시부터 오후 3시(동부 시간)까지 관심 있는 분들과 일대일 미팅을 진행할 예정입니다. 미팅 예약을 원하는 참석자는 John Perez에게 jperez@dboralcapital.com으로 연락할 수 있습니다.
Ernexa Therapeutics (NASDAQ : ERNA) a annoncé sa participation à la prochaine D. Boral Capital Inaugural Global Conference, prévue le 14 mai 2025 au The Plaza Hotel à New York. Le président-directeur général de la société, Sanjeev Luther, sera disponible pour des réunions individuelles avec les parties intéressées de 9h00 à 15h00 (heure de l'Est). Les participants souhaitant planifier des rendez-vous peuvent contacter John Perez à jperez@dboralcapital.com.
Ernexa Therapeutics (NASDAQ: ERNA) hat seine Teilnahme an der bevorstehenden D. Boral Capital Inaugural Global Conference angekündigt, die am 14. Mai 2025 im The Plaza Hotel in New York City stattfindet. Der Präsident und CEO des Unternehmens, Sanjeev Luther, steht von 9:00 bis 15:00 Uhr (ET) für Einzelgespräche mit Interessenten zur Verfügung. Teilnehmer, die Termine vereinbaren möchten, können John Perez unter jperez@dboralcapital.com kontaktieren.
- None.
- None.
Cambridge, Massachusetts--(Newsfile Corp. - May 8, 2025) - Ernexa Therapeutics (NASDAQ: ERNA), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.
Sanjeev Luther, President & CEO, will be hosting one-on-one meetings on May 14th from 9:00 A.M. to 3:00 P.M. (ET).
To register for one-on-one meetings with management at The Plaza Hotel in New York City, interested parties should contact John Perez at jperez@dboralcapital.com.
About Ernexa Therapeutics
About Ernexa TherapeuticsErnexa Therapeutics (NASDAQ: ERNA) is developing innovative cell therapies for the treatment of advanced solid tumors and autoimmune disease. Ernexa’s core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into induced mesenchymal stem cells (iMSCs). Ernexa’s allogeneic synthetic iMSCs provide a scalable, off-the-shelf treatment solution, without needing patient-specific cell harvesting.
Ernexa is developing two highly innovative cell therapy products, both currently in preclinical stages. ERNA-101 is the company’s lead cell therapy product, designed to activate and regulate the immune system’s response to recognize and attack cancer cells. ERNA-102 is a cell therapy product designed to target inflammation and treat autoimmune disease. The company’s initial focus is to develop ERNA-101 for the treatment of ovarian cancer.
For more information, visit www.ernexatx.com.
About D. Boral Capital
D. Boral Capital LLC is an investment bank headquartered in New York which provides advisory and financing solutions to middle market and emerging growth companies. The Company has a proven track record of offering strategic guidance to clients across the globe in any sector, with access to capital from the USA, Asia, Europe, Middle East, and Latin America.
D. Boral Capital is a leader on Wall Street, having aggregated over
For further information:
Ernexa Therapeutics
Sharon Golubchik
6094180058
sharon@raynzhealth.com
www.ernexatx.com
Source Ernexa Therapeutics
FAQ
When is Ernexa Therapeutics (ERNA) participating in the D. Boral Capital Conference?
Who will represent Ernexa Therapeutics (ERNA) at the D. Boral Capital Conference?
What are the meeting hours for Ernexa Therapeutics (ERNA) at the D. Boral Capital Conference?
How can investors schedule meetings with Ernexa Therapeutics (ERNA) management at the conference?
